Microlessons in Echocardiography and HCM Series
Watch the Microlesson in Echocardiography and HCM Series Playlist on ASE’s YouTube Channel.
ASE thanks the following faculty members for their contributions to this microlesson content:
- Ted Abraham, MD, FASE
- Steven Lester, MD, FASE
- Carol Mitchell, PhD, RDMS, RDCS, RVT, RT(R), ACS, FASE
- Dermot Phelan, MD, PhD, FASE
- Madeline Jankowski, BS, ACS, RDCS, FASE
Sign Up for HCM Resource Updates
NEW! ASE Guideline on Multimodality Cardiovascular Imaging of Patients with HCM
Updated June 2022
Read the Updated ASE Guideline on HCM
The Role of Echocardiography in Hypertrophic Cardiomyopathy Poster
This professionally illustrated 16”x20” poster is designed to help cardiovascular sonographers and physicians diagnose hypertrophic cardiomyopathy (HCM). The piece was included as an insert in the October 2021 print issue of the Journal of the American Society of Echocardiography (JASE). We are pleased to also make it available as a PDF for download and print on-demand.
The poster outlines the use of echocardiography in the assessment of HCM.
This valuable tool was authored by Allison Hays, MD, FASE, and Karan Kapoor, MD, in collaboration with Judy W. Hung, MD, FASE, Dermot Phelan, MD, PhD, FASE, and David H. Wiener, MD, FASE.
Download The Role of Echocardiography in HCM Poster
ASE On-Demand Webinars
Hypertrophic Cardiomyopathy (HCM) State-of-the-Art: Comprehensive Echocardiographic Evaluation – Part 1This on-demand webinar, FREE for ASE Members and Nonmembers, provides an overview on the utility of echocardiography in the diagnosis and prognosis of HCM. In addition, the speakers outline identifying markers of HCM and provide guidance for sonographers and echo reviewers on what elements of the exam are most important in echo reporting. You can claim 1.0 AMA PRA Category 1 Credit™.
Hypertrophic Cardiomyopathy State-of-the-Art: Comprehensive Echocardiographic Evaluation – Part 2
This webinar, FREE for ASE Members and Nonmembers, addresses echocardiographic guidance for septal reduction in HCM, risk stratification for sudden cardiac death in HCM, and includes a case-based presentation on challenging HCM cases and clinical conundrums. You can claim 1.0 AMA PRA Category 1 Credit™.
ASE gratefully acknowledges Bristol Myers Squibb for their support of these resources.